Barclays raised the firm’s price target on Ambev (ABEV) to $2.50 from $2 and keeps an Equal Weight rating on the shares. While Ambev has begun to set itself up to “combat” upcoming margin pressures in the coming quarters, in Q1 the company saw better than expected volumes, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABEV: